News

This Pick Withstood the GLP-1 Challenge. Stick With the Stock.
We said to buy shares in early July 2024, when the stock had gotten knocked down to $192. The market was concerned a new Eli Lilly pill would reduce patients’ obstructive sleep apnea, or OSA, enough ...
Better sleep without surgery or CPAP: The oral appliance that’s changing the way we treat sleep apnea
Content by Advanced Dental Sleep Treatment Center. Thankfully, there is a treatment that’s effective, sustainable and ...
ResMed Inc. stock falls Friday, underperforms market
Shares of ResMed Inc. RMD shed 1.42% to $254.40 Friday, on what proved to be an all-around rough trading session for the ...
Psychology Today1d
A Sleep Doctor’s Experience With CPAP
A Behavioral Sleep Medicine Specialist wore CPAP for a year to better empathize with her patients. This is what she learned.
Healio1d
CPAP use may drive lower mortality in patients with IPF plus OSA vs. IPF only
Fewer patients with idiopathic pulmonary fibrosis and obstructive sleep apnea died vs. patients with idiopathic pulmonary ...
Smart Home Healthcare Market to Hit Valuation of US$ 194.51 Billion by 2033 | Astute Analytica
Smart home healthcare market will evolve toward embedded edge intelligence, energy-aware sensors, and interoperable standards ...